$47.73 0.57 (+1.21%)
2/13/2012 2:36 PM

AstraZeneca plc (ADR) (NYSE:AZN)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Featured Broker Partners


Advertisement